Doctors test tailored treatment to fight lymphoma while reducing harsh side effects
Disease control
Recruiting now
This study is testing a new, personalized approach to treating advanced Hodgkin lymphoma. It uses an early scan to see how well the initial treatment is working, then adjusts the follow-up therapy based on those results. The goal is to control the cancer effectively while trying …
Phase: PHASE2 • Sponsor: National Research Center for Hematology, Russia • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC